Acadian Asset Management
PLRX icon

Acadian Asset Management’s Pliant Therapeutics PLRX Stock Holding History

Acadian Asset Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.75M Hold
2,416,508
– – ﹤0.01% 987
2026
Q1 		$3.04M Buy
2,416,508
+51,839
+2% +$65.4K ﹤0.01% 835
2025
Q4 		$2.88M Sell
2,364,669
-4,873
-0.2% -$7.32K ﹤0.01% 817
2025
Q3 		$3.5M Buy
2,369,542
+739,129
+45% +$1.13M 0.01% 744
2025
Q2 		$1.88M Buy
1,630,413
+409,967
+34% +$579K ﹤0.01% 846
2025
Q1 		$1.64M Buy
+1,220,446
New +$7.41M ﹤0.01% 809
2022
Q3 		– Sell
-10,753
Closed -$86K – 1802
2022
Q2 		$86K Buy
10,753
+6,663
+163% +$42.7K ﹤0.01% 1387
2022
Q1 		$27K Buy
+4,090
New +$41.7K ﹤0.01% 1536

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Acadian Asset Management's PLRX Position: Q2 2026 in Review

Acadian Asset Management held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 2,416,508 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #987.

Acadian Asset Management first reported a position in PLRX in Q1 2022 and has held it in 8 quarters since. The position peaked at $3.5M in Q3 2025. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Acadian Asset Management held 2,416,508 shares of Pliant Therapeutics worth $2.75M as of Q2 2026.
  • Acadian Asset Management left its Pliant Therapeutics share count unchanged in Q2 2026.
  • Pliant Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #987 holding.
  • Acadian Asset Management first reported a position in Pliant Therapeutics in Q1 2022 and has held it in 8 quarters since.
  • Acadian Asset Management's Pliant Therapeutics position peaked at $3.5M in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.